Study to Assess the Efficacy and Safety of Treatment of Articular Cartilage Lesions With CartiLife®

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 3, 2014

Primary Completion Date

February 23, 2017

Study Completion Date

February 23, 2017

Conditions
Articular Cartilage Lesion of the Knee
Interventions
DRUG

CartiLife®

CartiLife® is beads (1.0 to 1.5 mm in diameter) in suspension, developed from autologous chondrocytes. The beads are implanted the volume of 1 cm3 per the capacity of the syringe to the affected area through injection with fibrin adhesive through minimal arthrotomy.

PROCEDURE

Microfracture

The surgery is performed by arthroscopy, after the joint is cleaned of calcified cartilage. Through use of an awl, the surgeon creates tiny fractures in the subchondral bone plate.

Sponsors
All Listed Sponsors
collaborator

Kyunghee University Medical Center

OTHER

collaborator

Gangnam Severance Hospital

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Ewha Womans University

OTHER

lead

Biosolution Co., Ltd.

INDUSTRY